MHRA clarifies position on off-label Avastin
Roche’s drug has been used for years to treat wet AMD, an indication for which it is not specifically licensed
Read More
Tag: CCGs
Nearly half of CCGs rated ‘requires improvement’ or ‘inadequate’
A new report from the National Audit Office has found that In 2017-18, 42% (87 of 207) of Clinical Commissioning Groups (CCGs) were rated either ‘requires improvement’ or ‘inadequate’, with as little as 10% rated as ‘outstanding’.
Read More
STP relationships strengthening but plans lack funding, finds survey
Working relationships within controversial sustainability and transformation plans (STPs) has strengthened significantly in the last five months, but NHS finance leads believe the capital being streamed into projects is simply not enough to reduce funding issues across the Service.
Read More
Most CCG cancer services need improving, says NHS England
The majority of clinical commissioning groups in England need to improve their cancer services to meet ambitious targets laid out by the Cancer Taskforce that are expected to save an extra 30,000 lives a year by 2020.
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
